7 months ago
PEN
AnalystsDavid RescottDavid Rescott's Stock Forecasts
AnalystsDavid Rescott
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#3664 out of 4426 analysts
Average Return
-1.11%
Win Rate
33%9 out of 27
Risk vs Reward
Poor
Good
David Rescott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Penumbra IncPEN | +141.93% | $124.98 | $302.36 | 2022-07-20 - 2023-07-19 | Strong Buy |
Si Bone IncSIBN | +60.10% | $12.08 | $19.34 | 2022-12-20 - 2023-12-08 | Strong Buy |
Penumbra IncPEN | +45.36% | $199.65 | $290.22 | 2022-09-13 - 2023-09-12 | Strong Buy |
Penumbra IncPEN | +28.26% | $204.05 | $261.72 | 2022-02-23 - 2023-02-23 | Strong Buy |
Inari Medical IncNARI | +11.87% | $56.36 | $63.05 | 2023-07-19 - 2023-12-08 | Buy |
David Rescott Analyst Color
Get additional color on David Rescott's coverage of popular stocks
8 months ago
IRTC
David Rescott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Boston Scientific CorpBSX | 2 | Buy | $63.00 | +14.65% | Maintains | 3 months ago |
Si Bone IncSIBN | 4 | Strong Buy | $31.00 | +60.29% | Maintains | 4 months ago |
Penumbra IncPEN | 10 | Strong Buy | $345.00 | +53.99% | Maintains | 4 months ago |
Axonics IncAXNX | 5 | Buy | $70.00 | +23.20% | Maintains | 4 months ago |
Edwards Lifesciences CorpEW | 1 | Buy | $107.00 | +54.67% | Initiates Coverage On | 5 months ago |
Medtronic PLCMDT | 1 | Hold | $90.00 | +13.42% | Initiates Coverage On | 5 months ago |
Inari Medical IncNARI | 1 | Buy | $79.00 | +25.30% | Initiates Coverage On | 5 months ago |
Irhythm Technologies IncIRTC | 4 | Strong Buy | $154.00 | +72.72% | Maintains | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.